<--- Back to Details
First PageDocument Content
Amides / Organochlorides / Pharmacology / Benzazepines / Diuretics / Otsuka Pharmaceutical / Aripiprazole / Tolvaptan / Nabiximols / Chemistry / Pharmaceutical sciences / Organic chemistry
Date: 2014-10-02 03:37:36
Amides
Organochlorides
Pharmacology
Benzazepines
Diuretics
Otsuka Pharmaceutical
Aripiprazole
Tolvaptan
Nabiximols
Chemistry
Pharmaceutical sciences
Organic chemistry

PH ARMACEUTICAL SEGMENT Otsuka-people creating new products for better health worldwide Pharmaceutical Segment Overview

Add to Reading List

Source URL: www.otsuka.com

Download Document from Source Website

File Size: 2,54 MB

Share Document on Facebook

Similar Documents

Medical Hypotheses, 234–246  http://intl.elsevierhealth.com/journals/mehy A tale of two cannabinoids: The therapeutic rationale for combining

Medical Hypotheses, 234–246 http://intl.elsevierhealth.com/journals/mehy A tale of two cannabinoids: The therapeutic rationale for combining

DocID: 1pj4f - View Document

Cannabinoids and Multiple Sclerosis – M.J.Atha  © IDMU Ltd 2006 Cannabinoids and Multiple Sclerosis A Literature review

Cannabinoids and Multiple Sclerosis – M.J.Atha © IDMU Ltd 2006 Cannabinoids and Multiple Sclerosis A Literature review

DocID: 17DzR - View Document

Microsoft PowerPoint - Wayne Hall.ppt [Compatibility Mode]

Microsoft PowerPoint - Wayne Hall.ppt [Compatibility Mode]

DocID: 10SLB - View Document

O’Shaughnessy’s • Summer 2003 —17—  Bayer Buys Rights to Market GWP’s Cannabis Extract By Fred Gardner GW Pharmaceuticals, the British company that has conducted successful clinical trials of cannabis-based

O’Shaughnessy’s • Summer 2003 —17— Bayer Buys Rights to Market GWP’s Cannabis Extract By Fred Gardner GW Pharmaceuticals, the British company that has conducted successful clinical trials of cannabis-based

DocID: 10QP8 - View Document

PH ARMACEUTICAL SEGMENT  Otsuka-people creating new products for better health worldwide Pharmaceutical Segment Overview

PH ARMACEUTICAL SEGMENT Otsuka-people creating new products for better health worldwide Pharmaceutical Segment Overview

DocID: T3F4 - View Document